CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

Baker, Andrew (Principal Investigator)
Brittan, Mairi (Co-investigator)

Deanery of Clinical Sciences

Status	Finished
Effective start/end date	1/01/19 → 30/06/24

Funding

EU government bodies: £1,064,614.00

1 Article

Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development
Ballmann, M. Z., Raus, S., Engelhart, R., Kaján, G. L., Beqqali, A., Hadoke, P. W., Van Der Zalm, C., Papp, T., John, L., Khan, S., Boedhoe, S., Danskog, K., Frängsmyr, L., Custers, J., Bakker, W. A. M., Van Der Schaar, H. M., Arnberg, N., Lemckert, A. A. C., Havenga, M. & Baker, A. H., 1 Sept 2021, (E-pub ahead of print) In: Journal of Virology.
Research output: Contribution to journal › Article › peer-review

Open Access
File